Key result
Obesity may negatively impact the efficacy of common cancer treatments, preventing these patients from benefiting equitably from standard therapies.
Obesity may impact the efficacy of common cancer treatments, highlighting the need for future studies to optimize clinical care for this population.
May warrant vigilance in dosing obese cancer patients; leaves open the need for prospective trials to confirm and optimize regimens.
Patients who are obese make up a substantial proportion of individuals with cancer and may not benefit equitably from treatment. The impact of obesity on the efficacy of common cancer treatments is reviewed, and considerations are discussed for future studies that may contribute to the evidence base for the clinical care of this growing population.
No takes yet. Share an insight, caveat, or question.
Ross et al. (2019) studied this question. Obesity may negatively impact the efficacy of common cancer treatments, preventing these patients from benefiting equitably from standard therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: